Skip to main content
Barbarajean Magnani on Muck Rack

Barbarajean Magnani

As seen in: American Journal of Health-System Pharmacy, Archives of Pathology & Laboratory Medicine, Archives of Pathology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbarajean

Contact Barbarajean, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Protecting the Pathology Commons in the Digital Era

|
By Stephen Smith, Sharad Khurana, Barbarajean Magnani, Chloe Brady
| allenpress.com
In the rush to innovate and profit, we risk losing the pathology commons. The “commons” is a term used in legal, ethical, and historical contexts to refer to “shared resources in which each stakeholder has an equal interest.”22  We are specifically defining the pathology commons as the set of openly shareable and modifiable knowledge the profession relies on for practice and scholarship.
Open in Who Shared Issue with article?

Interpretation and Utility of Drug of Abuse Screening Immunoassays: Insights From Laboratory Drug Testing Proficiency Surveys

|
By Matthew D. Krasowski, Gwendolyn A. McMillin, Barbarajean Magnani, Annabel Dizon
| Archives of Pathology Verified
Article Citation: Matthew D. Krasowski, Gwendolyn A. McMillin, Stacy E. F. Melanson, Annabel Dizon, Barbarajean Magnani, and Christine L. H. Snozek (2019) Interpretation and Utility of Drug of Abuse Screening Immunoassays: Insights From Laboratory Drug Testing Proficiency Surveys. Archives of Pathology & Laboratory Medicine In-Press. Early Online Release Matthew D. Krasowski, MD, PhD; Gwendolyn A. McMillin, PhD; Stacy E. F.
Open in Who Shared Issue with article?

The opioid abuse and misuse epidemic: Implications for pharmacists in hospitals and health systems

|
By Mary McPherson, Carl Gainor, Cynthia L. Gaston, Tai C. Kwong, Barbarajean Magnani, Jacob T. Painter
| American Journal of Health-System Pharmacy Verified
Summary U.S. sales of prescription opioids increased fourfold from 1999 to 2010, with an alarming rise in deaths and emergency department visits associated with the use of fentanyl, hydrocodone, oxycodone, and other opioid medications. Signs and symptoms of opioid toxicity may include altered mental status, hypoventilation, decreased bowel motility, central nervous system and respiratory depression, peripheral vasodilation, pulmonary edema, hypotension, bradycardia, and seizures.
Open in Who Shared Issue with article?
See all 3 licensed articles (6 Total)